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Abstract
DUPONT, DYLAN. An Alternative Synthetic Pathway to γ-Lactam Compounds
Through the Application of Novel Reformatsky-Type Chemistry. Department
of Chemistry, June 2020
ADVISOR: James C. Adrian Jr. Ph.D.
It is the intent of the present report to relate the results of our attempt to elucidate and
optimize a novel preparation of γ-lactam compounds. To achieve this end, it is proposed that
the use of novel Reformatsky-type chemistry may provide a viable means. Generally, it has
herein been validated that employment of α-amino ketones in traditional Reformatsky
chemistry will form the traditional Reformatsky ester-adduct, and that this adduct is capable
of spontaneously undergoing an intramolecular cyclization event that yields the desired γlactam moiety. The main hurdle in this chemical pathway is an energetic one, as the
cyclization event has showed itself to be slightly less spontaneous than predicted. However,
this obstacle can be overcome by altering the solvent identity as to increase the heating
capacity of the system.
The present study was hindered by inefficacies in the preparations of ketone starting
materials, all of which performed with markedly less fidelity than was purported by the
literature. Therefore, improvements to the curation of starting materials will be necessary.
Barring necessary amendments to the preparation of starting materials, the presently
proposed Reformatsky-type chemistry appears to have great potential as a cogent and useful
addition to the repertoire of synthetic strategies.
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1. Introduction
Since their introduction in the mid-20th century, penicillin derivatives have
comprised the majority of our library of antibacterial pharmaceuticals.1, 2 The aspect of their
structure responsible for their antibacterial activity is a four membered cyclic amide known
as the 𝛽-lactam ring (Fig. 1.a). The mechanism by which the 𝛽-lactam interacts with bacteria
involves opening of the ring to inhibit transpeptidase and carboxypeptidase, enzymes crucial
in the formation of peptidoglycan cell walls.3 Therefore, the bacterial lethality of penicillins
is attributed to the inhibition of peptidoglycan synthesis, which compromises bacteria cell
wall integrity. Given the high fidelity of this interaction, 𝛽-lactam antibiotics have been
heavily relied upon since their initial application. Due to the constant exploitation of this
biochemical vulnerability, microbial resistance to these medications has developed.4 In
response, researchers have begun to explore possible analogues to combat bacterial
resistance. One such category of analogues that would logically be of interest are compounds
containing the γ-lactam moiety (Fig. 1.b).

Figure 1. (a) General structure of the 𝛽-lactam moiety. (b) General structure of the γ-lactam
moiety.

In 1986 the first two biologically active γ-lactam analogues were reported by
independent research groups, one being Baldwin and co-workers (1) and another at Eli Lilly
and Company (2).5 Both reported synthesizing penem analogues containing γ-lactam cores,
1

while the Eli Lilly group also reported slight biological activity of a carbapenem γ-lactam
analogue which also incorporated the presence of an electron withdrawing group (2).6-8

Figure 2. The first biologically active γ-lactam compounds.3

Multiple reports had previously concluded an absence of biological activity in
synthesized γ-lactams, and so it was assumed that the strict presence of the 𝛽-lactam moiety
endowed antibiotics with their activity. However, the findings of these two research groups
disqualified the notion that only the 𝛽-lactam core itself could grant drugs antibiotic
properties. It was agreed upon that the delocalization of the lactam nitrogen lone pair by the
𝜋-character of the thiophene-type ring or cyclopentene of the bicyclic system must be
responsible for the reactivity of the analogues. This conclusion agreed with the findings of
the Lilly group regarding 1 (Figure 2).9 This implies that the five-membered γ-lactam ring is
less inclined to mimic the ring opening mechanism by which the more strained fourmembered 𝛽-lactam ring derives its activity. For the γ-lactam core to be a reactive antibiotic,
and thereby be capable of replacing its predecessor, a more electrophilic aspect must be
present for these compounds to participate in a suicide inhibition mechanism similar to that
of 𝛽-lactam antibiotics.
Compounds containing γ-lactam cores have since been shown to display a broad array of
other biological activities, including antibiotic, cytotoxic, anti- inflammatory and anticancer
effects through various mechanisms.5 In fact, several non-antibacterial γ-lactam based
2

pharmaceuticals have already been brought to market. One such successful drug is an
anticonvulsant with the trade name of Keppra™ (3).5, 10 Another example is Briviact™ (4), a
levetiracetam analogue- commonly referred to as brivaracetam- involving a cis-n-propyl
substituent at the 𝛽 position of the lactam, which was found to be ten-fold more effective in
the treatment of epilepsy than its precursor 3 (Fig. 3).5, 11 In a similar fashion, it has been
shown that potency, metabolic stability and bioavailability can be enhanced by altering
substituents on the lactam ring of γ-lactam based antitumor drugs that act as histone
deacetylase inhibitors.12 While the reactivities of these compounds are greatly influenced by
the substituents of the lactam ring, the lactam moiety itself is also responsible for some
properties demonstrated by these species. Pharmacokinetic studies found that compounds
containing 𝛿-lactams exhibited weaker histone deacetylase inhibition than those containing γlactams. Docking studies concluded that 𝛿-lactams were less effective due to the poor fit of
the expanded lactam ring within the enzyme’s active site.13, 14

Figure 3. Anticonvulsant drugs Briviact™ (4) and its precursor Keppra™ (3).

Given the wide range of biological capabilities of γ-lactam containing compounds,
and the contribution of all structural aspects to their degree of reactivity, it seems that the
utilization of biologically active starting reagents would best orient any proposed synthetic
pathway towards biologically active end products. The literature supports this notion as there
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exists a history of lactam syntheses involving amino acid and peptide starting materials. One
such example is the formulation of renin inhibitory peptides containing the γ-lactam moiety.
Renin, the enzyme responsible for a cascade pathway which physiologically leads to
retention of sodium and water, plays a critical role in the maintenance of blood pressure.
Artificial peptide mimics of renin pathway substrates- known as angiotensins- have been
found to be successful inhibitors of the renin-angiotensin system. However, the longevity of
the hypotensive effect these inhibitors produce has been essentially limited to the duration of
the drug infusion. Therefore, improvement in the lifetime of the inhibitor-enzyme complex
was desirable. This was accomplished by introducing a γ-lactam moiety to the peptide
backbone of an angiotensin-type isostere. Formation of this ring structure along the backbone
increased conformational rigidity, allowing the inhibitor to resist metabolic re-conformation
upon encountering its target (Fig. 4). The success of this strategy is notable in that the
presence of the lactam group did not interfere with substrate activity, thus reinforcing the
notion that the lactam moiety will not be rejected by proteo-metabolic enzymes. This study
employed two synthetic routes to achieve their desired γ-lactam bridged dipeptide isostere,
with the most relevant preparation involving the formation of a γ-lactam structure via an
intramolecular displacement reaction induced by basification of a methylated methionine
sidechain.15-17

4

Figure 4. The pathway used to induce the intramolecular displacement and subsequent
cyclization of a methionine residue side chain to its peptide backbone.17

Generally, there is a history of employing Reformatsky-type chemistry, involving the
formation of zinc enolates which are reactive towards polar reagents with 𝜋-character, to
induce cyclization in 𝛼-amino acid type reagents to yield lactams. Many such preparations
have been reported regarding the synthesis of 𝛽-lactams. One such technique employs imines
to react with cyclized zinc-enolate adducts derived from 𝛼-amino esters prepared via LDA.
This reaction produces 𝛽-lactam structures that have maintained the N-protecting groups and
the various possible substituents of the imine (Figure 5). These reactions offered good yield
as well as remarkable stereoselectivity, favoring the trans conformation.18 Other similar
pathways to 𝛽-lactams, which exercise slightly alternative chemistry, have also been reported
as generally stereoselective for the cis conformation.19

Figure 5. Reported Reformatsky-type chemistry involving 𝛼-amino esters and imines to
form 𝛽-lactams.18

5

Intramolecular cyclizations have also been achieved at the carbonyl position of
certain species using Barbier-type chemistry. These reactions, in much the same manner as
Grignard reactions, reduce carbonyl positions to alcohols through the exploitation of alkyl
halides. Much work has been reported concerning the employment of samarium diiodide
(SmI2) as the reducing agent in Barbier-type chemistry (Fig. 6). SmI2 is widely reactive and
the conditions required for the formation of carbocycles via this catalyst are mild. Given that
the mechanism proceeds through a radial intermediate, introduction of a lewis basic
substituent can direct the cyclization such that stereospecific carbocycles are formed in a
predictable fashion.20

Figure 6. The formation of carbocycles via intramolecular cyclization induced by Barbiertype chemistry catalyzed by samarium diiodide.20

This notion was applied to Reformatsky-type chemistry, where identical substrates
with a priori 𝛼-haloester substituents were subjected to react with SmI2 in place of alkyl zinc
(Fig. 7). This chemistry successfully yielded lactone rings of various sizes with various
degrees of stereospecificity. Reactions wherein the identity of the ester substrate was some 𝛽haloacetoxy ketone proceeded with great stereochemical fidelity regarding 1,2 and 1,3asymmetric inductions, producing 𝛿-valerolactone compounds. Such lactones synthesized by
way of this chemistry are structurally similar to the pharmaceutically important compound
6

known as compactin.21 This compound, isolated from Penicillium citrium in the search for
additional antibacterial species, was found to act as an HMG-CoA Reductase inhibitor and
was the first statin to be tested in clinical trials. It has served as the template for a majority of
subsequent statin drugs.22 However, it was observed by Molander, et al. that the obligate
stereospecificity required for pharmacological import was only achieved when the directing
stereocenter was within the Sm (III) chelate intermediate. It was also noted that Reformatskytype reactions catalyzed by SmI2 never appear to yield unsaturated lactones, whereas
traditional Reformatsky chemistry catalyzed by alkyl zincs may tend towards dehydration of
the newly formed alcohol position. However, this approach is not applicable to bulky
ketones. Such groups sterically hinder the formation of the lactone forming C-C bond in the
intermediate configuration. Therefore, the breadth of viable ring substituents is limited by the
mechanistic pathway of this chemistry.21

Figure 7. The application of samarium diiodide catalyzed intramolecular cyclizations to
Reformatsky-type chemistry. 21

Similar chemistry has also been proven viable in the formation of γ-lactams. It has long been
known that Blaise-type chemistry using THF as solvent is capable of synthesizing 𝛽-enamino
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esters with great fidelity.23 The Blaise reaction is in itself a deviation of Reformatsky
chemistry. Its accepted mechanistic pathway involves an 𝛼-iminezincate ester intermediate
which results from the complexation of 𝛼-bromozinc esters with nitriles. This is opposed to
traditional Reformatsky reactions, which mechanistically include the formation of 𝛼bromozinc ester dimers that interact with carbonyl moieties. It has been reported that 𝛽enamino esters produced by enhanced Blaise chemistry involving 𝛼-amino nitrile derivatives
of 𝛼-amino acids can yield 4-aminopyrrolidinone, a γ-lactam compound. The initial general
approach used to induce the intramolecular cyclization involved reduction and deprotection
of the resulting 𝛽-enamino ester. However, this approach resulted in a complex mix of poor
yield. Yields and stereospecificity were improved through further protection of the 𝛼-amino
nitrile. The major products obtained by the subsequent Blaise reaction were 2imidazolidinone analogues, while the minor products, acyclic enamino esters, could be
converted to the major product by introduction of NaH. These compounds were then reduced
and subjected to hydrogenolysis to give the desired γ-lactams (Figure 8).24 Particular
reduction conditions imparted particular diastereotopic outcomes in good yields. However,
possible substituents are limited to the γ and nitrogen positions of the lactam. Furthermore,
the only substituent types confirmed using this approach are alkyl groups and benzyl.

8

Figure 8. General approach to the preparation of γ-lactams by way of Blaise-type chemistry.
Only major products are included. It should also be noted that the most stereoselective
approach involved iso-propyl at the R1 position, resulting in a 99-fold preference for the cis
conformation following reduction with sodium cyanoborohydride.21

It is the intention of the current report to introduce a new approach to the preparation
of γ-lactam compounds. The proposed pathway should produce more substituted γ-lactams
with a wider variety of substituents, which will in turn grant entry to the modification of
chemical species with γ-lactam cores. To enhance the probability of biologically active end
products, we wish to use L-amino acid starting materials in order to exploit the chiral pool.
These Fmoc-protected amino acids are activated to allow for the formation of 𝛼-amino
ketones, invoking conditions under which the amine is deprotected. Subsequent reprotection
of the 𝛼-amino ketone, and subjection of this compound to Reformatsky-type conditions,
produces an adduct which independently cyclizes to give the desired γ-lactam (Figure 9).

9

Figure 9. Generalization of the synthetic pathway currently proposed.

Variability in substituent identity may be introduced by this general pathway at three
of the five ring positions: identity of the amino acid controls the substituent at the γ position
as its side chain remains present, the ketone forming substituent at what would be the Cterminus of the amino acid is present at the 𝛽 position and removal of the N-protecting group
would allow for alterations at the N-position. Outcomes using the described pathway to
synthesize various γ-lactam compounds are described herein.
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2. Results & Discussion
The presently proposed pathway can be conceived of in two sequential processes: the
preparation of N-protected cathinone-type reagents and their subsequent employment in the
Reformatsky-type chemistry of interest. Each aspect of the preparation has been compartmentalized and addressed in an individualistic manner.
2.1. Preparation of the N-protected cathinone-type materials
Initiation of this procedure requires the preparation of α-amino acid chlorides. This
was easily accomplished by sonicating commercially obtained Fmoc-amino acids with
thionyl chloride, as dictated by the literature.25 This activated acid was then taken up in a
“one-pot” fashion and subjected to Friedel-Crafts chemistry. It is worthy of note that
catalyzing this reaction with a small excess of aluminum chloride resulted in cleavage of the
Fmoc protecting group, as reported by DiGioia and co-workers.26 The resulting free amine
was subsequently isolated and re-protected by some easily removable substituent (Scheme 1).

Scheme 1. Pathway traversed to acquire the N-protected cathinone-type starting materials.

Several limitations presented themselves upon execution of this process, the first of
which being the breadth of allowable aromatic moieties installed via the Friedel-Crafts
acylation. It is known that Friedel-Crafts chemistry is incapable of substituting both mildly
and strongly deactivated aromatics. Accordingly, this chemistry was found to be successful
11

in substituting the activated acid when the aromatic moiety employed was either benzene or
toluene. However, more activated species, such as anisole, gave poor yields. This is in
alignment with the literature, which reports that such nucleophilic species tend to complex
with aluminum chloride.27, 28 Such complexing renders the electrophilic-aromatic substitution
of moderately to strongly activated species a non-viable preliminary step for sequential
synthetic pathways. Further constraining our scope of possible aromatic ketones was the
apparent inability of species bearing multiple mildly activating substituents to participate in
the desired chemistry. Attempts to convert the activated acid halides to o-xylene ketones
resulted in poor yields. This particular result could not be reconciled with expectations.
Meanwhile, the range of possible protecting groups added to the free amine was limited by
its resilience towards Reformatsky conditions and the desire for a γ-lactam end-product
easily suited to further manipulation. The protecting group only complicated this phase of the
pathway when the identity of the group was trifluoro acetyl. Recovery of the ketone was less
efficient when the protecting group was incorporated following the formation of the free
amine and was markedly decreased when the amino acid identity was L-alanine.
2.2. Formation of γ-lactam compounds
The resulting collection of N-protected cathinone-type compounds were subsequently
employed in Reformatsky-type chemistry to attain γ-lactam species as described by scheme
2. The conditions were altered such that the identities of the solvent and nickel catalyst were
varied in concert to enhance the efficacy of the present chemistry. The first nickel catalyst
used was [1,3-Bis(diphenylphosphino)propane]dichloronickel (II) (Ni(dppp)Cl2). Modest
yields were obtained following a separation made challenging both by a persistent emulsion
that presented itself upon quenching and residual nickel material that was not consumed
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within the emulsion. The second nickel catalyst utilized was Bis(triphenylphosphine)nickel
(II) chloride (Ni(tppp)Cl2), which presented with similarly modest yields but a less persistent
emulsion that did not result in residual nickel material in the aqueous phase during
separation. While the identity of the nickel (II) catalyst did not have a notable effect on the
yield, the identity of the solvent appeared to be of greater import to the efficiency and
efficacy of the reaction. A sequence of solvents was exploited to manipulate the heating
capacity of the system to address the inefficacy of the anticipated spontaneous cyclization of
the Reformatsky adduct.

Scheme 2. Formation of the desired γ-lactam via novel Reformatsky-type chemistry

Generally, most attempts led to the formation of a mixture of adduct and cyclized
lactam. The traditional Reformatsy aspect of the chemistry occurred with expected fidelity,
and so our efforts came to be focused on ushering the consistently formed adduct towards
spontaneous cyclization. The mechanistic pathway of this phase is illustrated in figure 10.
Initially, the system composition included dry dichloromethane. The collection of Nprotected cathinone-type compounds previously prepared were employed under such
conditions, and all appeared to yield some mix. It appears that L-glycine material may have
produced greater total yields as well as possibly having resulted in more favorable adduct13

lactam ratios comparatively to the L-alanine population. Given that excess time was allotted
to all preparations according to TLC, it was determined that raising the reflux point of the
system might provide conditions sufficient to increase the probability of achieving the proper
intermediate orientation for the intramolecular interaction that is the quintessence of the
cyclization event.

Figure 10. Mechanistic pathway underlying the second phase of the second phase of the
general synthetic pathway, describing both the formation of the traditional Reformatsky
adduct and the subsequent crucial cyclization event.

It followed that the same chemistry was attempted in tetrahydrofuran. The trend of
lower total yields for the L-alanine compounds continued in the new solvent. However, it
was confirmed that under these conditions all ester adduct species formed from the Ac-
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alanine-toluene ketone performed the desired intramolecular cyclization. In the case of the
Ac-glycine-toluene ketone, it seems that the adduct only partially cyclized. It could be the
case that the less sterically incumbered glycine aspect of the adduct has somewhat greater
probability of existing in a wider range of three-dimensional orientations relative to the rest
of the adduct. This increase in possible locants could explain the apparent decreased
probability of the glycine adduct orienting itself in a manner conducive to spontaneous
cyclization. However, further trials are necessary to substantiate this claim. The results for
the Ac-alanine-toluene trial supported the notion that increased thermal input could improve
γ-lactam formation, thus cyclization of the glycine species was reattempted within a system
utilizing dichloroethane as solvent to increase its heating capacity. Strangely, these
conditions unexpectedly led to a null reaction. It is suspected that impurities or some other
procedural error compromised this trial, therefore further work is necessary to assess the
viability of this solvent for use in the present chemistry.

15

3. Conclusions
The potential utilization of Reformatsky-type chemistry in the preparation of γ-lactam
compounds from α-amino acid starting materials has shown promise. Once the allowed
aromatic ketone starting materials were identified, the Reformatsky-type chemistry
efficaciously formed the traditional Reformatsky adduct. The proposed novel application of
this Reformatsky chemistry was complicated by the intramolecular cyclization of this adduct,
which proved less spontaneous than predicted. However, this issue was seemingly resolved
by increasing the heating capacity of the system. Under the proper conditions, ketone
formation and subsequent employment of the Reformatsky-type chemistry produce the
desired lactams in good yields. Further experimentation will be required to optimize both
phases of this pathway. Firstly, it will be necessary to enhance the efficacy of the in situ
cyclization of the adduct. Secondly, it will also be necessary to continue attempting to
incorporate a spectrum of possible substituents on the lactam core as to grow the library of
compounds accomplished by this chemistry.

16

4. Future Works
Improving the efficacy of the intramolecular cyclization event will be key to
optimizing the Reformatsky phase of the pathway. It was observed that the use of THF as
solvent during this phase of the preparation lead to greater yields of cyclized adduct when
compared to prior attempts made with DCM as solvent. It is believed that the greater
refluxing point of the THF system granted the adduct sufficient energy to perform the desired
cyclization, thus it would seem that the use of solvents with even higher boiling points would
further enhance the efficacy of the cyclization event. In particular, future trials should
implement dichloroethane as the choice solvent. The use of this solvent inexplicably resulted
in a null reaction during the present study. This bizarre finding will require reaffirmation if it
is to disprove the notion that greater system heating capacity is the solution to the apparent
energetic hurdle challenging the cyclization event.
The most obvious avenue by which the α-amino acid modification phase could be
enhanced, granting a wider variety of α-amino ketones, would be to abandon the FriedelCrafts electrophilic aromatic substitution approach to forming the ketones. With knowledge
that the overall pathway is viable with aromatic ketones prepared by this method when using
singly substituted, weakly activated aromatic moieties, it might be necessary to move
towards testing the feasibility of ketones with normal alkyl chains, bulky alkyl groups or
other possible substituents. No steric implications should be introduced to the process
according to the accepted mechanisms for the Reformatsky reaction and the presently
proposed cyclization event. Another possible avenue could be the use of different amino acid
starting materials, as only glycine and alanine were explored in the present report. Both
modifications would contribute to expanding the library of compounds produced through this

17

novel synthetic pathway and lend the current proposal greater validity regarding its
applicability as a general approach to produce γ-lactam compounds.

18

5. Experimental Section
5.1. General methods
NMR spectra were acquired using a 400 MHz Bruker Avance III. The resulting
spectroscopic data was presented across a delta scale in units of parts per million (ppm)
relative to a tetramethylsilane (TMS) signal lock introduced to the sample upon collection of
the isolated product in deuterated chloroform.
5.2. General procedure for N-protected α-amino ketone materials
Thionyl chloride (15.0 mmol, 1.10 mL) was introduced to a solution of Fmocprotected L-amino acid (1.50 mmol) in CH2Cl2 (15.0 mL). The system was placed under an
inert atmosphere and then sonicated for approximately 1 h. The system was then placed in
vacuo to afford the isolated acid chloride in the form of a white solid.25 This material was
taken up in toluene (approximately 10 mL) and the resulting solution received a portion of
pulverized AlCl3 (4.14 mmol, 0.55 g). The reaction was stirred under argon for
approximately 3.5 h before being quenched with 1M HCl(aq.) (approximately 8 mL). The
biphasic system was then separated, and the organic phase was washed 3x with 1M HCl(aq.).
The aqueous portions were collected and basified by K2CO3 to a pH of 9. CH2Cl2
(approximately 10 mL) was then introduced to induce a biphasic system which was
subsequently subjected to some protecting-group reagent (1.8 mmol).26 The organic phase
was then separated, the aqueous layers washed 3x with CH2Cl2, and the combined organic
portions were then washed sequentially with deionized H2O, saturated NaHCO3 and brine.
The washed organic bulk was then dried over MgSO4, filtered and placed in vacuo to afford
the isolated N-protected cathinone type material in the form of a white solid.
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5.2.1. 2-(N-CBZ-amino)-1-(methylphenyl)-1-propanone (13)
The title compound was obtained by masking the free alanine-amine with benzyl
chloroformate. Yield: 78%; 1H NMR (CDCl3) δ 7.83 (d, 2H, J = 0.02), 7.30 (m, 9H), 7.18 (d,
2H, J = 0.02), 5.88 (d, 1H, J = 0.01), 5.38 (m, 1H), 5.12 (s, 2H), 2.42 (s, 3H), 1.43 (d, 3H, J =
0.01).
5.2.2. 2-(N-Ac-amino)-1-(methylphenyl)-1-propanone (14)
The title compound was obtained by masking the free alanine-amine with acetic anhydride.
Yield: 78%; 1H NMR (CDCl3) δ 7.89 (d, 2H, J = 0.02), 7.29 (d, 2H, J = 0.02), 6.63 (d, 1H, J
= 0.01), 5.46 (m, 1H), 2.43 (s, 3H), 2.06 (s, 3H), 1.42 (d, 3H, J = 0.01).
5.2.3. 2-(N-TFA-amino)-1-(methylphenyl)-1-propanone (15)
The title compound was obtained by masking the free alanine-amine with trifluoroacetic
anhydride. Yield: 26%; 1H NMR (CDCl3) δ 7.84 (d, 2H, J = 0.02), 7.23 (d, 2H, J = 0.02),
5.22 (m, 1H), 4.47 (d, 1H, J = 0.01), 2.35 (s, 3H), 1.42 (d, 3H, J = 0.02).
5.2.4. 2-(N-CBZ-amino)-1-(methylphenyl)-1-ethanone (16)
The title compound was obtained by masking the free glycine-amine with benzyl
chloroformate. Yield: 66%; 1H NMR (CDCl3) δ 7.86 (d, 2H, J = 0.02), 7.38 (m, 6H), 7.29 (d,
2H, J = 0.02), 5.82 (d, 1H, J = 0.01), 5.15 (s, 2H), 4.70 (d, 2H, J = 0.01), 2.42 (s, 3H).
5.2.5. 2-(N-Ac-amino)-1-(methylphenyl)-1-ethanone (17)
The title compound was obtained by masking the free glycine-amine with Acetic anhydride.
Yield: 62%; 1H NMR (CDCl3) δ 7.87 (d, 2H, J = 0.02), 7.29 (d, 2H, J = 0.02), 6.58 (s, 1H),
4.73 (d, 2H, J = 0.01), 2.43 (s, 3H), 2.10 (s, 3H).
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5.2.6. 2-(N-TFA-amino)-1-(methylphenyl)-1-ethanone (18)
The title compound was obtained by masking the free glycine-amine with trifluoroacetic
anhydride. Yield: 51%; 1H NMR (CDCl3) δ 7.87 (d, 2H, J = 0.02), 7.24 (d, 2H, J = 0.02),
4.71 (d, 2H, J = 0.01), 2.36 (s, 3H).
5.3. General procedure for γ-lactam materials
Bis(triphenylphosphine)nickel (II) chloride (Ni(tppp)Cl2) (0.02 mmol, 0.0133 g) and
methyl bromoacetate (0.663 mmol, 0.0634 mL) were added to a solution of the cathinonetype material (0.51 mmol) in dry organic solvent (approximately 5 mL). The system was set
stirring and refluxing under an inert atmosphere prior to the dropwise addition of 1M diethyl
zinc in hexanes (5.1 mmol, 5.1 mL). The reaction proceeded in this manner for
approximately 3 h before being quenched with 1M HCl(aq.) (approximately 8 mL) and then
being subsequently set to stir for an additional 30 min. The organic phase was then separated,
the aqueous phase was washed 3x with aliquots of the organic solvent which were combined
with the primary organic portion and then washed sequentially with deionized H2O, saturated
NaHCO3 and brine. The washed organic bulk was then dried over MgSO4, filtered and placed
in vacuo to afford the desired γ-lactam compound in the form of a brownish-yellow oil.
5.3.1. 3,3-hydroxyl,methylphenyl-4-methyl-5-(N-CBZ)-azolidone (19)
The title compound was obtained through the employment of 13 in the Reformatsky-type
chemistry presently proposed in dry CH2Cl2. Total cyclization was not afforded. Yield: 39%;
1

H NMR (CDCl3) δ 7.89 (d, 2H, J = 0.02), 7.31 (m, 14H), 6.23 (s, 1H), 3.76 (s, 1.5H), 3.15

(m, 3H), 2.30 (s, 3H), 1.45 (d, 1H, J = 0.02), 1.37 (d, 2H, J = 0.02).
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5.3.2. 3,3-hydroxyl,methylphenyl-4-methyl-5-(N-Ac)-azolidone (20)
The title compound was obtained through the employment of 14 in the Reformatsky-type
chemistry presently proposed in both dry CH2Cl2 and THF. Complete adduct cyclization was
afforded using THF as solvent. Yield: 30% (CH2Cl2), 21% (THF); 1H NMR (CDCl3) δ 7.28
(d, 2H, J = 0.02), 7.14 (d, 2H, J = 0.02), 5.99 (d, 1H, J = 0.02), 3.49 (s, 3H, only observed in
CH2Cl2), 2.99 (q, 2H, J = 0.04, shift for product of THF system), 2.93 (q, 2H, J = 0.04, shift
for product of CH2Cl2 system), 2.32 (s, 3H), 2.04 (s, 4H), 0.81 (d, 3H, J = 0.02).
5.3.3. 3,3-hydroxyl,methylphenyl-5-(N-CBZ)-azolidone (21)
The title compound was obtained through the employment of 16 in the Reformatsky-type
chemistry presently proposed in dry CH2Cl2. A slight amount of ester-adduct is suspected to
have gone uncyclized. However, cyclization in this instance was notably improved relative to
the preparation of 19. Yield: 43%; 1H NMR (CDCl3) δ 7.84 (d, 2H, J = 0.02), 7.31 (m, 9H),
4.64 (s, 1H), 3.73 (m, 3H), 2.93 (q, 2H, J = 0.04, 0.22).
5.3.4. 3,3-hydroxyl,methylphenyl-5-(N-Ac)-azolidone (22)
The title compound was obtained through the employment of 17 in the Reformatsky-type
chemistry presently proposed in THF and dry CH2Cl2. In this instance as well, it seems
cyclization was better achieved in THF as opposed to CH2Cl2. Yield: 72% (in CH2Cl2), 73%
(in THF); 1H NMR (CDCl3) δ 7.79 (d, 2H, J = 0.02), 5.95 (s, 1H), 3.49 (s, 3H), 2.81 (q, 2H,
J = 0.04, 0.14), 2.25 (s, 3H), 1.87 (s, 3H).
5.3.5. 3,3-hydroxyl,methylphenyl-5-(N-TFA)-azolidone (23)
The title compound was obtained through the employment of 18 in the Reformatsky-type
chemistry presently proposed in dry CH2Cl2. Yield: 49%; 1H NMR (CDCl3) δ 7.19 (m, 4H),
3.73 (s, 0.6H), 2.77 (m, 2H), 2.27 (d, 2H, J = 0.02), 1.18 (s, 3H).
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